Clinical Trials Directory

Trials / Unknown

UnknownNCT05239130

Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects

Open, Non-comparative, Multicentre Clinical Investigation to Evaluate the Performance and Safety of the Medical Device Auralya® (Hyaluronic Acid-dermal Filler) in the Treatment of Facial Dermal Tissue Defects

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
I.R.A. Istituto Ricerche Applicate S.p.A. · Network
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The Research Question of the present study is the following: in a population of men and women presenting facial dermal tissue defects (scars, depressed plaques, and lipodystrophy defects) will cross-linked hyaluronic acid (Auralya®) significantly decrease and / or improve their appearance, results observed after 4, 8 and 12 weeks?

Detailed description

Auralya® action is to increase the volume of dermal-epidermal tissue based on the natural ability of hydrophilic hyaluronic acid molecules to bind to an amount of water many times greater than their weight. This allows to fill the intradermal spaces and integrate the intercellular matrix, conferring turgidity to the tissues. The cross-linking of the hyaluronic acid contained in the product has the effect of more stable and durable filling over time. These characteristics allow Auralya® to be used as a temporary filler for subcutaneous areas to correct small defects in the dermal tissue due to lipodystrophies or the presence of fibrotic tissues as scars, caused by pathologies or trauma.

Conditions

Interventions

TypeNameDescription
DEVICEAuralyaAuralya® is a sterile, injectable, non-pyrogenic, re-absorbable medical product made of reticulated hyaluronic acid of non-animal origin, produced via bacterial fermentation. Auralya® is a colourless gel contained in a pre-filled, graduated, disposable, and sterile glass syringe with a Luer adapter.

Timeline

Start date
2022-03-21
Primary completion
2022-12-11
Completion
2022-12-11
First posted
2022-02-14
Last updated
2022-10-25

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT05239130. Inclusion in this directory is not an endorsement.